Search Results - "Judd W. Moul"

Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer by HALABI, Susan, LIN, Chen-Yen, KELLY, W. Kevin, FIZAZI, Karim S, MOUL, Judd W, KAPLAN, Ellen B, MORRIS, Michael J, SMALL, Eric J

“…Prognostic models for overall survival (OS) for patients with metastatic castration-resistant prostate cancer (mCRPC) are dated and do not reflect significant…”
Get full text

Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer by FIZAZI, Karim S, HIGANO, Celestia S, NELSON, Joel B, GLEAVE, Martin, MILLER, Kurt, MORRIS, Thomas, NATHAN, Faith E, MCINTOSH, Stuart, PEMBERTON, Kristine, MOUL, Judd W

“…PURPOSE As part of the ENTHUSE (Endothelin A Use) program, the efficacy and safety of zibotentan (ZD4054), an oral specific endothelin A receptor antagonist,…”
Get full text

A Critical Analysis of the Long-Term Impact of Radical Prostatectomy on Cancer Control and Function Outcomes by Boorjian, Stephen A, Eastham, James A, Graefen, Markus, Guillonneau, Bertrand, Karnes, R. Jeffrey, Moul, Judd W, Schaeffer, Edward M, Stief, Christian, Zorn, Kevin C

“…Abstract Context The optimal management strategy for men with newly diagnosed clinically localized prostate cancer remains a matter of debate. Numerous series…”
Get full text

Management of Biochemical Recurrence After Primary Treatment of Prostate Cancer: A Systematic Review of the Literature by Punnen, Sanoj, Cooperberg, Matthew R, D’Amico, Anthony V, Karakiewicz, Pierre I, Moul, Judd W, Scher, Howard I, Schlomm, Thorsten, Freedland, Stephen J

“…Abstract Context Despite excellent cancer control with the treatment of localized prostate cancer (PCa), some men will experience a recurrence of disease. The…”
Get full text

Satisfaction and Regret after Open Retropubic or Robot-Assisted Laparoscopic Radical Prostatectomy by Schroeck, Florian R, Krupski, Tracey L, Sun, Leon, Albala, David M, Price, Marva M, Polascik, Thomas J, Robertson, Cary N, Tewari, Alok K, Moul, Judd W

“…Abstract Background To counsel patients adequately, it is important to understand the variables influencing satisfaction and regret following prostatectomy…”
Get full text

Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology by Droz, Jean‐Pierre, Balducci, Lodovico, Bolla, Michel, Emberton, Mark, Fitzpatrick, John M., Joniau, Steven, Kattan, Michael W., Monfardini, Silvio, Moul, Judd W., Naeim, Arash, van Poppel, Hendrik, Saad, Fred, Sternberg, Cora N.

“…Prostate cancer is the most prevalent cancer in men and predominantly affects older men (aged ≥70 years). The median age at diagnosis is 68 years; overall,…”
Get full text

Postoperative Radiation Therapy for Pathologically Advanced Prostate Cancer After Radical Prostatectomy by Stephenson, Andrew J, Bolla, Michel, Briganti, Alberto, Cozzarini, Cesare, Moul, Judd W, Roach III, Mack, van Poppel, Hein, Zietman, Anthony

“…Abstract Context Approximately 15–25% of men who undergo radical prostatectomy for localized prostate cancer (PCa) will experience recurrence of their cancer;…”
Get full text

Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression by Gesztes, William, Schafer, Cara, Young, Denise, Fox, Jesse, Jiang, Jiji, Chen, Yongmei, Kuo, Huai-Ching, Mwamukonda, Kuwong B., Dobi, Albert, Burke, Allen P., Moul, Judd W., McLeod, David G., Rosner, Inger L., Petrovics, Gyorgy, Tan, Shyh-Han, Cullen, Jennifer, Srivastava, Shiv, Sesterhenn, Isabell A.

“…TP53 is one of the most frequently altered genes in prostate cancer. The precise assessment of its focal alterations in primary tumors by immunohistochemistry…”
Get full text

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes by Cookson, Michael S, Aus, Gunnar, Burnett, Arthur L, Canby-Hagino, Edith D, D'Amico, Anthony V, Dmochowski, Roger R, Eton, David T, Forman, Jeffrey D, Goldenberg, S Larry, Hernandez, Javier, Higano, Celestia S, Kraus, Stephen R, Moul, Judd W, Tangen, Catherine, Thrasher, J Brantley, Thompson, Ian

“…The American Urological Association Prostate Guideline Update Panel was charged with updating the Guidelines for Clinically Localized Prostate Cancer. In…”
Get more information

The Changing Face of Prostate Cancer by COOPERBERG, Matthew R, MOUL, Judd W, CARROLL, Peter R

“…Prostate cancer remains the most common noncutaneous human malignancy, and the second most lethal tumor among men. However, the natural history of the disease…”
Get full text

Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer by Moul, Judd W.

“…The current issue of Cancer includes a report on a concise, randomized controlled trial (RCT) with long‐term follow‐up that favors combined androgen blockade…”
Get full text

Downsides of Robot-assisted Laparoscopic Radical Prostatectomy: Limitations and Complications by Murphy, Declan G, Bjartell, Anders, Ficarra, Vincenzo, Graefen, Markus, Haese, Alexander, Montironi, Rodolfo, Montorsi, Francesco, Moul, Judd W, Novara, Giacomo, Sauter, Guido, Sulser, Tullio, van der Poel, Henk

“…Abstract Context Robot-assisted laparoscopic radical prostatectomy (RALP) using the da Vinci Surgical System (Intuitive Surgical, Sunnyvale, CA, USA) is now in…”
Get full text

The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel by Muller, Berrend G., Fütterer, Jurgen J., Gupta, Rajan T., Katz, Aaron, Kirkham, Alexander, Kurhanewicz, John, Moul, Judd W., Pinto, Peter A., Rastinehad, Ardeshir R., Robertson, Cary, Rosette, Jean, Sanchez‐Salas, Rafael, Jones, J. Stephen, Ukimura, Osamu, Verma, Sadhna, Wijkstra, Hessel, Marberger, Michael

“…Objective To establish a consensus on the utility of multiparametric magnetic resonance imaging (mpMRI) to identify patients for focal therapy. Methods…”
Get full text

Salvage radiation in men after prostate‐specific antigen failure and the risk of death by Cotter, Shane E., Chen, Ming Hui, Moul, Judd W., Lee, W. Robert, Koontz, Bridget F., Anscher, Mitchell S., Robertson, Cary N., Walther, Philip J., Polascik, Thomas J., D'Amico, Anthony V.

“…BACKGROUND: A survival benefit has been observed with salvage radiation therapy (RT) for prostate‐specific antigen (PSA) failure after radical prostatectomy…”
Get full text

Predictors of Prostate Cancer–Specific Mortality After Radical Prostatectomy or Radiation Therapy by PING ZHOU, CHEN, Ming-Hui, MCLEOD, David, CARROLL, Peter R, MOUL, Judd W, D'AMICO, Anthony V

“…We evaluated predictors of prostate cancer-specific mortality (PCSM) after prostate-specific antigen (PSA) failure after radical prostatectomy (RP) or…”
Get full text

Hormone naive prostate cancer： predicting and maximizing response intervals by Moul, Judd W

“…Hormone naive advanced prostate cancer is subdivided into two disease states： biochemical recurrence and traditional M 1 （metastatic） prostate cancer and…”
Get full text

Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery by Demark-Wahnefried, Wendy, Polascik, Thomas J, George, Stephen L, Switzer, Boyd R, Madden, John F, Ruffin, 4th, Mack T, Snyder, Denise C, Owzar, Kouros, Hars, Vera, Albala, David M, Walther, Philip J, Robertson, Cary N, Moul, Judd W, Dunn, Barbara K, Brenner, Dean, Minasian, Lori, Stella, Philip, Vollmer, Robin T

“…Background: Prostate cancer affects one of six men during their lifetime. Dietary factors are postulated to influence the development and progression of…”
Get full text

Prostate specific antigen recurrence after definitive therapy by Freedland, Stephen J, Moul, Judd W

“…We estimate that approximately 70,000 men yearly have prostate specific antigen-only recurrence after failed definitive therapy. The ideal salvage therapy for…”
Get more information

Erectile function outcome reporting after clinically localized prostate cancer treatment by Burnett, Arthur L, Aus, Gunnar, Canby-Hagino, Edith D, Cookson, Michael S, D'Amico, Anthony V, Dmochowski, Roger R, Eton, David T, Forman, Jeffrey D, Goldenberg, S Larry, Hernandez, Javier, Higano, Celestia S, Kraus, Stephen, Liebert, Monica, Moul, Judd W, Tangen, Catherine, Thrasher, J Brantley, Thompson, Ian

“…In conjunction with the assignment to update the Guidelines for Management of Clinically Localized Prostate Cancer, the American Urological Association…”
Get more information

Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy by AMLING, Christopher L, RIFFEBURGH, Robert H, CHUNG, Andrew K, MCLEOD, David G, SUN, Leon, MOUL, Judd W, LANCE, Raymond S, KUSUDA, Leo, SEXTON, Wade J, SODERDAHL, Douglas W, DONAHUE, Timothy F, FOLEY, John P

“…To determine if obesity is associated with higher prostate specific antigen recurrence rates after radical prostatectomy (RP), and to explore racial…”
Get full text